Table 4 Immunohistochemical characteristics of patients

HNF1β

31

26/31(83.87%)

1/31(3.23%)

4/31(12.90%)

WT-1

60

2/60(3.33%)

55/60(91.67%)

3/60(5.00%)

ER

57

3/57(5.26%)

41/57(71.93%)

13/57(22.81%)

PR

50

1/50(2.00%)

41/50(82.00%)

8/50(16.00%)

NapsinA

60

29/60(48.33%)

22/60(36.67%)

9/60(15.00%)

CK7

66

61/66(92.42%)

3/66(4.55%)

2/66(3.03%)

P53

54

16/54(29.63%)

16/54(29.63%)

22/54(40.74%)

P16

25

13/25(52.00%)

4/25(16.00%)

8/25(32.00%)

PAX8

41

40/41(97.56%)

1/41(2.44%)

0

CK20

34

0

32/34(94.12%)

2/34(5.88%)

CD10

18

1/18(5.56%)

14/18(77.78%)

3/18(16.67%)

CD15

47

24/47(51.06%)

11/47(23.40%)

12/47(25.53%)

Vim

38

7/38(18.42%)

28/38(73.68%)

3/38(7.89%)

CA125

37

26/37(70.27%)

4/37(10.81%)

7/37(18.92%)